ArticleAmerican journal of translational research2020

The immunosuppressant fingolimod ameliorates experimental autoimmune myasthenia gravis by regulating T-cell balance and cytokine secretion.

Ya-Ting Luo et al.PubMed ↗Full text ↗

No numbers read from the abstract.